Alternatives to Insilico Medicine

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

AI biologist platform accelerating preclinical drug development by integrating biological data for smarter decisions.

AI drug discovery startup that learns directly from patient biology to identify and design novel medicines, focusing on oncology and fibrosis.

Agentic drug company using a 27B biological foundation model to simulate human cellular responses to drugs.

Building the world's first scientific superintelligence platform and autonomous labs.

Revolutionizing drug design using quantum computing, AI, and personalized medicine.

AI-powered drug discovery platform for accelerated molecular design.

Biotech startup developing an AI-powered drug platform targeting pancreatic cancer.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for personalized cell therapy development and manufacturing.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel therapeutics for neurodegenerative diseases using advanced biological insights.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Advance every cancer decision.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Global marketplace connecting researchers with human biospecimens for life science research.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

AI-powered spatial biology platform for precision medicine and drug development.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotech company focused on designing and developing novel biological solutions.

Biotechnology company

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.